Bedaquiline resistance in patients with drug-resistant tuberculosis in Cape Town, South Africa: a retrospective longitudinal cohort study

Brigitta Derendinger, Anzaan Dippenaar, Margaretha de Vos, +21

The Lancet Microbe

Treatment outcomes 24 months after initiating short, all-oral bedaquiline-containing or injectable-containing rifampicin-resistant tuberculosis treatment regimens in South Africa: a retrospective cohort study

Norbert Ndjeka, Jonathon R. Campbell, Graeme Meintjes, +12

The Lancet Infectious Diseases

Delamanid for rifampicin-resistant tuberculosis: a retrospective study from South Africa

Erika Mohr-Holland, Jennifer Hughes, Anja Reuter, +14

European Respiratory Journal

Initiation of antiretroviral therapy at high CD4+ cell counts is associated with positive treatment outcomes

Viviane D. Lima, Anja Reuter, P. Richard Harrigan, +8

AIDS

Effect of compensatory evolution in the emergence and transmission of rifampicin-resistant Mycobacterium tuberculosis in Cape Town, South Africa: a genomic epidemiology study

Galo A. Goig, Fabrizio Menardo, Zubeida Salaam-Dreyer, +11

The Lancet Microbe

Critical changes to services for TB patients during the COVID-19 pandemic

Vivian Cox, Lynne Wilkinson, Anna Grimsrud, +5

The International Journal of Tuberculosis and Lung Disease

Pulmonary TuberculosisCritical ChangesTb PatientsCovid-19 PandemicTuberculosis +3

Implementing novel regimens for drug-resistant TB in South Africa: what can the world learn?

Norbert Ndjeka, Jennifer Hughes, Anja Reuter, +12

The International Journal of Tuberculosis and Lung Disease

Tuberculosis PreventionPharmacotherapyDrug ResistanceClinical EpidemiologyClinical Trials +20

Whole-Genome Sequencing Has the Potential To Improve Treatment for Rifampicin-Resistant Tuberculosis in High-Burden Settings: a Retrospective Cohort Study

Helen Cox, Galo A. Goig, Zubeida Salaam-Dreyer, +13

Journal of Clinical Microbiology

Potential contribution of HIV during first-line tuberculosis treatment to subsequent rifampicin-monoresistant tuberculosis and acquired tuberculosis drug resistance in South Africa: a retrospective molecular epidemiology study

Helen Cox, Zubeida Salaam-Dreyer, Galo A. Goig, +14

The Lancet Microbe

Injectable-free regimens containing bedaquiline, delamanid, or both for adolescents with rifampicin-resistant tuberculosis in Khayelitsha, South Africa

Erika Mohr-Holland, Anja Reuter, Jennifer Furin, +7

EClinicalMedicine